Clinical Trial Update: Intranasal Insulin for Prevention of Type 1 Diabetes [Phase 3]

View source ↗

Summary

This document provides an update on a Phase 3 clinical trial evaluating intranasal insulin for prevention of Type 1 diabetes. The trial status is not specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Intranasal insulin (insulin)

Snippet

Sponsor: University of Turku | Conditions: Type 1 Diabetes | Phase 3 | Status: UNKNOWN